FastForward Innovations Limited (LON:FFWD) revealed that its portfolio firm, EMMAC Life Sciences Limited has secured pharmaceutical wholesaler and narcotics handling permits that will allow it to sell medical cannabis products in Germany.
The investment firm said the permits will allow EMMAC to “drive immediate revenue growth” in Germany, Europe’s largest medical cannabis market.
READ: FastForward Innovations updates on fundraising efforts at investee company Factom
“EMMAC is now poised to deliver immediate revenues from Germany and capitalise on the significant opportunities presented by the largest medical cannabis market in Europe, as we bring our products to market in 2020", said EMMAC’s chief executive Antonio Costanzo.
Shares in FastForward, which owns a 2.3% stake in EMMAC, jumped 11.1% to 7.5p in mid-afternoon trading on Tuesday.